eFFECTOR Therapeutics, Inc.‘s stocks are currently a part of 16 hedge funds’ portfolios, which represents 41.43% of the total amount of its stocks outstanding. This makes up a total of 17.05M shares of eFFECTOR Therapeutics, Inc.. Compared to the previous quarter, the number fell by -29.86% or -7.26M shares fewer. As for the holding position changes, 18.75% (3) of current hedge fund investors increased the number of shares held, 25% (4) of current holders sold a part of the shares held, and 12.5% (2) closed the holdings completely. 2 hedge funds are new holders of eFFECTOR Therapeutics, Inc. stock in Q1 2023, it is 12.5% of total holders.
